- Drugs (psychoactive) - World Health Organization (WHO)
About 296 million people aged 15-64 had used psychoactive drugs in 2021 and about 39 5 million people are estimated to be affected by drug use disorders (harmful pattern of drug use or drug dependence) It is estimated that about 0 6 million death annually are attributable to drug use with about 420 000 male and 160 000 female deaths
- WHO Drug Information
Launched in 1987, WHO Drug Information communicates the latest international news and trends to regulatory agencies, academic and training institutions, researchers, consumer bodies, and pharmaceutical manufacturers and focuses on topics impacting the safety, efficacy and quality of medicines, medical products, herbals and biomedicines
- Drug use and road safety - World Health Organization (WHO)
The Unit works globally to improve health and well-being of populations by articulating, promoting, supporting and monitoring evidence-informed policies, strategies and interventions to reduce the burden associated with alcohol, drugs and addictive behaviours
- UN Commission approves WHO recommendations to place psychoactive . . .
The recommendations were developed by WHO Expert Committee on Drug Dependence--ECDD, which consists of global experts analyzing health risks and benefits of psychoactive substances circulating on global markets and alerting to include them under international control if evidence found that their use can cause harm for population health in
- Over 3 million annual deaths due to alcohol and drug use, majority . . .
A new report from the World Health Organization (WHO) highlights that 2 6 million deaths per year were attributable to alcohol consumption, accounting for 4 7% of all deaths, and 0 6 million deaths to psychoactive drug use Notably, 2 million of alcohol and 0 4 million of drug-attributable deaths were among men
- Expert Committee on Drug Dependence - World Health Organization (WHO)
The ECDD Information Repository is an open access database containing publications and information on psychoactive substances reviewed by the WHO Expert Committee on Drug Dependence (ECDD)
- Medicines - World Health Organization (WHO)
The first is regulatory issues, which can affect how medicines are bought to market, create lag times and cause the supply of medicines in some areas of the globe to be delayed long after they are available elsewhere High prices, misuse of drugs and poor or unreliable drug quality contribute to this issue
- WHO updates guidelines on opioid dependence treatment and overdose . . .
Out of 600,000 deaths attributed to drug use, about 450 000 are due to use of opioids according to the latest WHO estimates It is crucial that people with opioid dependence and those at risk of opioid overdose have access to prevention, harm reduction, treatment, and care, which are of good quality, affordable, ethical and evidence based
|